Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery

Bauer, 1997, Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery, Circulation, 95, 1242, 10.1161/01.CIR.95.5.1242 Warkentin, 1995, Heparin-induced thrombocytopenia in patients treated with low-molecular- weight heparin or unfractionated heparin, N Engl J Med, 332, 1330, 10.1056/NEJM199505183322003 Pouplard, 1999, Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin, Circulation, 99, 2530, 10.1161/01.CIR.99.19.2530 Williams RT, Damaraju LV, Mascelli MA, et al. Anti-platelet factor 4/heparin antibodies. An independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes. Circulation 2003;107:2307–12 Butterworth, 2002, Rapid disappearance of protamine in adults undergoing cardiac operation with cardiopulmonary bypass, Ann Thorac Surg, 74, 1589, 10.1016/S0003-4975(02)04016-X Spiess, 2000, Heparin. Beyond an anticoagulant, 169 Bates SM, Weitz JI. Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin. Am J Cardiol 1998;82(Suppl 1):12P–18P Kong, 1999, Clinical outcomes of bivalirudin for ischemic heart disease, Circulation, 100, 2049, 10.1161/01.CIR.100.20.2049 Bittl, 2001, Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina, Am Heart J, 142, 952, 10.1067/mhj.2001.119374 Lincoff, 2003, Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention, JAMA, 289, 853, 10.1001/jama.289.7.853 Puskas, 2001, Clinical outcomes, angiographic patency, and resource utilization in 200 consecutive off-pump coronary bypass patients, Ann Thorac Surg, 71, 1477, 10.1016/S0003-4975(01)02473-0 Angelini, 2002, Early and midterm outcome after off-pump and on-pump surgery in Beating Heart Against Cardioplegic Arrest Studies (BHACAS 1 and 2), Lancet, 359, 1194, 10.1016/S0140-6736(02)08216-8 Mariani, 1999, Procoagulant activity after off-pump coronary operation, Ann Thorac Surg, 67, 1370, 10.1016/S0003-4975(99)00265-9 Zehr, 2000, Pitfalls and results of immediate angiography after off-pump coronary artery bypass grafting, Heart Surg Forum, 3, 293 Kim KB, Lim C, Lee C, et al. Off-pump coronary artery bypass may decrease the patency of saphenous vein grafts. Ann Thorac Surg 2001;72(Suppl):S1033–7 Chesebro, 1987, Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I. A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge, Circulation, 76, 142, 10.1161/01.CIR.76.1.142 Wilensky, 1993, Intracoronary artery thrombus formation in unstable angina, J Am Coll Cardiol, 21, 692, 10.1016/0735-1097(93)90102-7 White, 2001, Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction, Lancet, 358, 1855, 10.1016/S0140-6736(01)06887-8 Nader, 1999, Blood product use in cardiac revascularization, Ann Thorac Surg, 68, 1640, 10.1016/S0003-4975(99)00827-9 Puskas, 1998, Off-pump multivessel coronary bypass via sternotomy is safe and effective, Ann Thorac Surg, 66, 1068, 10.1016/S0003-4975(98)00657-2 Calafiore, 1999, Multiple arterial conduits without cardiopulmonary bypass, Ann Thorac Surg, 67, 450, 10.1016/S0003-4975(98)01194-1 Khan NE, Mister R, De Souza AC, et al. A comparison of clinical outcomes, graft patency and neuropsychological function in patients undergoing coronary surgery with and without cardiopulmonary bypass. Circulation 2002;106(Suppl II):II-638 FitzGibbon, 1986, Coronary bypass graft fate. Angiographic study of 1,179 vein grafts early, one year, and five years after operation, J Thorac Cardiovasc Surg, 91, 773, 10.1016/S0022-5223(19)36000-3 Greinacher A, Lubenow N, Eichler P. Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia. Circulation 2003;108:2062–5. Vasquez, 2002, Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery, Ann Thorac Surg, 74, 2177, 10.1016/S0003-4975(02)04125-5 Davis, 2003, Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass, Ann Thorac Surg, 75, 264, 10.1016/S0003-4975(02)04299-6